Subtopic Deep Dive

← Silicon Nanostructures and Photoluminescence

Biocompatibility of Porous Silicon Nanostructures
Research Guide

What is Biocompatibility of Porous Silicon Nanostructures?

Biocompatibility of porous silicon nanostructures evaluates the cytotoxicity, hemocompatibility, degradation profiles, and immune responses of porous silicon materials in biological environments for biomedical applications.

Research focuses on porous silicon nanoparticles and films demonstrating low toxicity and controlled biodegradation in vivo. Key studies report successful use in fluorescence imaging, drug delivery, and cancer hyperthermia without adverse effects (Gu et al., 2013; Tamarov et al., 2014). Over 20 papers from 2010-2021 document these properties, with foundational works exceeding 300 citations.

Curated Papers

Key Challenges

Why It Matters

Porous silicon's proven biocompatibility enables safe implantable sensors and theranostic nanoparticles, as shown in vivo imaging without toxicity (Gu et al., 2013, 321 citations) and hyperthermia therapy (Tamarov et al., 2014, 168 citations). Degradation profiles support sustained drug release for retinal implants (Wu et al., 2010, 141 citations). This positions porous silicon for clinical translation in cancer therapy and biosensing (Tieu et al., 2018).

Key Research Challenges

Protein Corona Formation

Proteins adsorb onto porous silicon surfaces altering biocompatibility and targeting in vivo. Tzur-Balter et al. (2015) detail erosion mechanisms influenced by corona in neoplastic tissues. Control remains inconsistent across formulations.

Long-term Immune Response

Immune cell activation by porous silicon degradation products limits implant longevity. Tamarov et al. (2014) observe minimal responses in hyperthermia but long-term data gaps persist. Variability in pore size affects outcomes.

Controlled Degradation Rates

Balancing biodegradation speed for drug release versus structural integrity challenges applications. Wu et al. (2010) monitor real-time release via optical shifts but physiological variability complicates prediction. Models need refinement.

Essential Papers

Layer-by-layer biofunctionalization of nanostructured porous silicon for high-sensitivity and high-selectivity label-free affinity biosensing

Stefano Mariani, Valentina Robbiano, Lucanos Marsilio Strambini et al. · 2018 · Nature Communications · 402 citations

Abstract Nanostructured materials premise to revolutionize the label-free biosensing of analytes for clinical applications, leveraging the deeper interaction between materials and analytes with com...

In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles

Luo Gu, David J. Hall, Zhengtao Qin et al. · 2013 · Nature Communications · 321 citations

Radio frequency radiation-induced hyperthermia using Si nanoparticle-based sensitizers for mild cancer therapy

Konstantin Tamarov, Л. А. Осминкина, S. V. Zinovyev et al. · 2014 · Scientific Reports · 168 citations

Advances in Porous Silicon–Based Nanomaterials for Diagnostic and Therapeutic Applications

Terence Tieu, Marı́a Alba, Roey Elnathan et al. · 2018 · Advanced Therapeutics · 143 citations

Abstract This review provides a perspective on porous silicon (pSi)–based nanomaterials including nanoparticles, nanowires, and thin films, that are currently being used in advanced therapy, imagin...

Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles

Elizabeth C. Wu, Jennifer S. Andrew, Lingyun Cheng et al. · 2010 · Biomaterials · 141 citations

Laser-Processed Nanosilicon: A Multifunctional Nanomaterial for Energy and Healthcare

Andrei V. Kabashin, Ajay Singh, Mark T. Swihart et al. · 2019 · ACS Nano · 133 citations

This review describes promising laser-based approaches to produce silicon nanostructures, including laser ablation of solid Si targets in residual gases and liquids and laser pyrolysis of silane. T...

Silicon Nanomaterials for Biosensing and Bioimaging Analysis

Xiaoyuan Ji, Houyu Wang, Bin Song et al. · 2018 · Frontiers in Chemistry · 130 citations

Biochemical analysis in reliable, low-toxicity, and real-time manners are essentially important for exploring and unraveling biological events and related mechanisms. Silicon nanomaterial-based sen...

Reading Guide

Foundational Papers

Start with Gu et al. (2013, 321 citations) for in vivo proof of biodegradable non-toxic imaging; Wu et al. (2010, 141 citations) for optical drug release biocompatibility; Tamarov et al. (2014, 168 citations) for therapeutic safety data.

Recent Advances

Study Tieu et al. (2018, 143 citations) review for diagnostic/therapeutic advances; Mariani et al. (2018) for biofunctionalized biosensors; Moretta et al. (2021) for optical biosensing updates.

Core Methods

Electrochemical etching for porous silicon fabrication; time-gated fluorescence for in vivo tracking (Gu et al., 2013); optical reflectance shifts for degradation monitoring (Wu et al., 2010); RF hyperthermia with Si sensitizers (Tamarov et al., 2014).

How PapersFlow Helps You Research Biocompatibility of Porous Silicon Nanostructures

Discover & Search

Research Agent uses searchPapers('biocompatibility porous silicon cytotoxicity') to retrieve Gu et al. (2013, 321 citations), then citationGraph reveals Tamarov et al. (2014) and Tzur-Balter et al. (2015) clusters; findSimilarPapers expands to Tieu et al. (2018) review; exaSearch uncovers degradation studies.

Analyze & Verify

Analysis Agent applies readPaperContent on Gu et al. (2013) to extract in vivo toxicity data, verifyResponse with CoVe cross-checks claims against Tamarov et al. (2014); runPythonAnalysis plots degradation rates from Wu et al. (2010) optical data using pandas; GRADE scores evidence strength for biocompatibility claims.

Synthesize & Write

Synthesis Agent detects gaps in long-term immune data across papers, flags contradictions in degradation rates; Writing Agent uses latexEditText for biocompatibility review sections, latexSyncCitations integrates 10+ references, latexCompile generates PDF; exportMermaid visualizes degradation pathways.

Use Cases

"Extract and plot cytotoxicity data from porous silicon in vivo studies"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on Gu et al. 2013 and Tamarov et al. 2014 data) → researcher gets overlaid toxicity curves CSV.

"Write LaTeX review on porous silicon biocompatibility for implants"

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Tieu et al. 2018, Wu et al. 2010) + latexCompile → researcher gets compiled PDF with figures.

"Find open-source code for porous silicon simulation in biological media"

Research Agent → paperExtractUrls (Tzur-Balter et al. 2015) → paperFindGithubRepo → githubRepoInspect → researcher gets erosion model code with usage instructions.

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'porous silicon biocompatibility', structures report with GRADE-verified sections on cytotoxicity and degradation (Gu et al. 2013 baseline). DeepScan applies 7-step CoVe to Tieu et al. (2018) review, checkpoint-verifying therapeutic claims against Tamarov et al. (2014). Theorizer generates hypotheses on pore size optimization from Wu et al. (2010) optical data.

Try Doxa for Biocompatibility of Porous Silicon Nanostructures Research

Frequently Asked Questions

What defines biocompatibility in porous silicon nanostructures?

Biocompatibility assesses cytotoxicity, hemocompatibility, protein interactions, and biodegradation in biological media, as in Gu et al. (2013) in vivo imaging with no toxicity.

What are key methods for evaluating porous silicon biocompatibility?

Methods include in vivo fluorescence imaging (Gu et al., 2013), real-time optical drug release monitoring (Wu et al., 2010), and hyperthermia sensitizer tests (Tamarov et al., 2014).

Which papers lead in porous silicon biocompatibility citations?

Gu et al. (2013, 321 citations) on biodegradable imaging nanoparticles; Tamarov et al. (2014, 168 citations) on cancer hyperthermia; Wu et al. (2010, 141 citations) on drug release.

What open problems exist in porous silicon biocompatibility?

Challenges include standardizing protein corona effects (Tzur-Balter et al., 2015), predicting long-term immune responses, and scaling degradation control for clinical implants.